Akèy › Kansè pwostat rezistan a kastasyon › Maryland
Etid klinik pou Kansè pwostat rezistan a kastasyon nan Maryland
3 etid pou Kansè pwostat rezistan a kastasyon ap chèche patisipan nan sit nan Maryland.
Vil nan Maryland
Tèks ofisyèl etid la (Anglè)
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- University of Maryland, Baltimore
- Johns Hopkins Hospital, Baltimore
- Johns Hopkins Medical Institutions, Baltimore
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07225946A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Johns Hopkins University, Baltimore
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT07164443Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Ap rekriteFaz 1
Laj 18 a 100 · Gason · Mizajou Aug 13, 2026 · NCT05519449Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.